期刊文献+

HPLC-MS/MS法测定人血浆中奎硫平浓度的方法学研究 被引量:1

HPLC-MS/MS determination of quetiapine in human plasma
下载PDF
导出
摘要 目的:建立人血浆中奎硫平测定的 HPLC-MS/MS 法。方法:血浆蛋白用乙腈直接沉淀。采用 Thermo Hypurity C_(18)(2.0mm×150 mm,5μm)分析柱,以乙腈(含1%甲酸)-1%甲酸水溶液(80:20)为流动相,流速为0.2 mL·min^(-1);采用 ESI^+MRM进行离子方式监测。质谱检测参数:源电压3.5 kV,源温度100℃,去溶剂化温度200℃,锥孔气流速50 L·h^(-1),去溶剂化气流速350 L·h^(-1)。结果:血浆中奎硫平检测方法的线性范围为1.764~1806 ng·mL^(-1),最低检测限为0.88 ng·mL^(-1)。方法回收率为94.1%~104.8%,提取回收率均值为68.0%~72.3%,日内 RSD 小于10%,日间 RSD 小于15%。结论:本方法灵敏、准确,可用于奎硫平的药代动力学研究。 Objective:To develop an HPLC MS/MS method for determination of quetiapine in human plasma. Methods:The plasma proteins were precipitated by acetonitrile directly. The separation was performed on a Thermo Hypurity C18(2. 0 mm × 150 mm,5 μm)analytical column using acetonitrile(0. 1% formic acid) -0. 1% formic acid(80: 20)as the mobile phase at a flow rate of 0. 2 mL · min^-1. The analyses were detected by the electronic - spray ionization(ESI) -multiple reaction monitoring (MRM)mode. The MS detection parameters were as follows: the capillary voltage was 3.5 kV, source temperature was 100℃ , desolation temperature was 200℃ ,cone gas flow was 50 L · h^-1 and desolation flow was 350 L · h^-1. Results:The linear range of the plasma concentration of quetiapine was 1. 764 - 1806 ng · mL^-1 and limit of detection was 0. 88 ng · mL^-1. The method recovery was 94. 1% - 104. 8%. The extractive recovery of quetiapine was 68.0% - 72. 3%. The RSDs of intra - day and inter - day were less than 10% and 15 %, respectively. Conclusion:The method has high sensitivity and good selectivity,it can be used for the pharmacokinetic research of quetiapine.
出处 《药物分析杂志》 CAS CSCD 北大核心 2008年第5期706-708,共3页 Chinese Journal of Pharmaceutical Analysis
关键词 奎硫平 液相色谱-质谱联用 药代动力学 quetiapine HPLC - MS/MS pharmacokinetics
  • 相关文献

参考文献6

  • 1Small JG, Hirseh SR, Arvantis LA, et al. Quetiapine in patients with schizophrenia. A high - and low - dose double - blind comparison with placebo. Arch Gen Psychiatry, 1997,54(6) :549
  • 2Meonville BJ, Arvanitis IA, Thyrum PT, et al. Pharmacokinetics, tolerability and clinical effectiveness of quetiapine fumarate:an open -label trial in psychotic disorders. J Clin Psychiatry,2000,61(4):252
  • 3温预关,陈伟家,陆润基,陆欣乔.人血浆中富马酸奎硫平浓度的测定[J].中国临床药学杂志,2003,12(4):215-217. 被引量:5
  • 4Hasselstrom J, Linnet K. Fully automated on - line quantification of quetiapine in human serum by solid phase extraction and liquid chromatography. J Chromatogr B Analyt Technol Biomed Life Scl, 2005, 798 ( 1 ) :9
  • 5Mandrioli R, Fanali S, Ferranti A, et al. HPLC analysis of the novel antipsychotic drug quetiapine in human plasma. J Pharm Biorned Anal, 2002,30:969
  • 6Hasselstrom J, Linnet K. Quetiapine serum concentrations in psychiatric patients : the influence of comedication. Ther Drug Monlt, 2004, 26:48

二级参考文献5

  • 1Small JG, Hirsch SR, Arvantis LA, et al. Quetiapine in patients with schizophrenia. A high-and low-dose double-blind comparison with placebo[J]. Acta Gen Psychiatr, 1997,54(6) :549.
  • 2Mconville BJ, Arvanitis LA, Thyrum PT, et al. Pharmacokinetics, tolerability and clinical effectiveness of quetiapine fumarate: an open-label trial in psychotic disorders[J]. J Clin Psychiatry,2000,61(4):252.
  • 3Davis PC, Wong J, Gofvert O. Analysis and phamvacokinetics of quetiapine and two metabolites in human plasma using reversed-phase HPLC with ultraviolet and electrochemical detection[J]. J Pharm Bioned Anal,1999,20(1-2) :271.
  • 4付崇铭,王汝展.反相高效液相色谱法测定富马酸喹硫平片的含量[J].中国新药杂志,2002,11(2):144-146. 被引量:5
  • 5赵靖平,陈晋东,陈远光,舒良,马崔.喹硫平治疗精神分裂症随机双盲双模拟对照临床试验[J].中国新药杂志,2002,11(2):149-151. 被引量:27

共引文献4

同被引文献5

引证文献1

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部